茶叶聚醇对高尿酸诱导的损伤的治疗作用
Lingjuan Liu1,2, Lanjun Shuai1,3, Siyi He4
1Department of Pediatrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
Current medicinal chemistry
|January 9, 2025
概括
优化茶叶多可以保护大鼠的脏免受高尿血引起的损伤,在副作用较少的情况下优于allopurinol. 这为与高尿酸水平相关的脏并发症提供了有前途的治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 超尿血症 (HUA) 是由于尿素代谢异常导致尿酸沉积和潜在的损伤的结果.
- 目前的HUA治疗缺乏特异性,可能导致不良影响.
- 对HUA诱导的脏并发症研究新的治疗策略至关重要.
研究的目的:
- 评估优化茶叶聚醇配方和氨醇在切除后高尿素血的小鼠模型中对脏的保护作用.
- 阐明这些保护作用的潜在机制.
主要方法:
- 茶叶多混合物的配方和优化使用直角实验.
- 建立一个5/6切除的小鼠模型与饮食诱导的高尿素血症 (2%氧化酸).
- 评估功能标记物 (尿蛋白,血清尿酸,肌,尿素),病理 (HE染色,间歇性纤维化),细胞增殖/亡 (PCNA,TUNEL) 和分子标记物 (α-SMA,CD34,TGF-β).
主要成果:
- 茶叶中的多可显著降低血尿酸,尿素,肌素和尿蛋白水平,在患有切除的高尿素性大鼠中.
- 茶叶中的多减轻了脏间歇性纤维化,减少了管状上皮细胞的亡,促进了细胞增殖.
- 茶叶聚醇对脏损伤的保护作用超过了阿洛普林醇的保护作用.
结论:
- 优化茶叶聚醇有效地减轻脏损伤在结合切除术和高尿血的小鼠模型.
- 茶叶中的多是一种具有成本效益和安全的治疗选择,用于高尿血引起的损伤.
- 需要进一步研究茶叶多作为HUA相关脏疾病的新疗法.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
494
12:00Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
19.1K
相关概念视频
01:16Antihypertensive Drugs: Action of Diuretics
617
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
617
01:28Renal Drug Excretion: Tubular Secretion
117
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
117
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
01:11Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62
01:17Factors Affecting Renal Clearance: Renal Impairment
53
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
53
01:25Antihypertensive Drugs: Direct Renin Inhibitors
484
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
484